Bristol Myers Squibb Stock Price on October 31, 2024
| BMY Stock | USD 58.23 0.35 0.60% |
Below is the normalized historical share price chart for Bristol Myers Squibb extending back to June 01, 1972. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bristol Myers stands at 58.23, as last reported on the 23rd of November, with the highest price reaching 58.48 and the lowest price hitting 57.47 during the day.
If you're considering investing in Bristol Stock, it is important to understand the factors that can impact its price. Bristol Myers appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. We have found thirty technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol Myers' Downside Deviation of 1.5, mean deviation of 1.32, and Risk Adjusted Performance of 0.1281 to double-check if our risk estimates are consistent with your expectations.
At this time, Bristol Myers' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 15 B in 2024. . At this time, Bristol Myers' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings Ratio is likely to rise to 19.89 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop 7.28 in 2024. Bristol Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of January 1972 | 200 Day MA 48.4847 | 50 Day MA 53.462 | Beta 0.441 |
Bristol |
Sharpe Ratio = 0.1743
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BMY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.0 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Bristol Myers is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myers by adding it to a well-diversified portfolio.
Price Book 6.8896 | Enterprise Value Ebitda 31.8294 | Price Sales 2.5171 | Shares Float 2 B | Dividend Share 2.4 |
Related Headline
Capricor Therapeutics Headline on 31st of October 2024
STAT Capricor and the FDA A daring, risky filing strategy by statnews.com
Capricor Therapeutics plan to seek early approval for a stem cell therapy for patients with Duchenne muscular dystrophy is daring, adamfeuerstein writes.
Bristol Myers Valuation on October 31, 2024
It is possible to determine the worth of Bristol Myers on a given historical date. On October 31, 2024 Bristol was worth 53.8 at the beginning of the trading date compared to the closed value of 55.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bristol Myers stock. Still, in general, we apply an absolute valuation method to find Bristol Myers' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol Myers where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bristol Myers' related companies.
| Open | High | Low | Close | Volume | |
| 52.50 | 53.15 | 52.29 | 52.66 | 9,652,243 | |
10/31/2024 | 53.80 | 56.20 | 53.56 | 55.77 | 18,741,836 |
| 55.88 | 55.90 | 54.20 | 54.32 | 12,893,215 |
| Backtest Bristol Myers | | | Bristol Myers History | | | Bristol Myers Valuation | Previous | Next |
Bristol Myers Trading Date Momentum on October 31, 2024
| On November 01 2024 Bristol Myers Squibb was traded for 54.32 at the closing time. Highest Bristol Myers's price during the trading hours was 55.90 and the lowest price during the day was 54.20 . The net volume was 12.9 M. The overall trading history on the 1st of November contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 2.60% . The overall trading delta to current price is 8.88% . |
Bristol Myers Squibb Fundamentals Correlations and Trends
By evaluating Bristol Myers' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bristol financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bristol Myers Stock history
Bristol Myers investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bristol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bristol Myers Squibb will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bristol Myers stock prices may prove useful in developing a viable investing in Bristol Myers
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.1 B | 1.6 B | |
| Net Income Applicable To Common Shares | 5.7 B | 6 B |
Bristol Myers Quarterly Net Working Capital |
|
Bristol Myers Stock Technical Analysis
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bristol Myers Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Bristol Myers Squibb cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bristol Myers November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By undertsting and applying Bristol Myers stock market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns
Bristol Myers Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bristol Myers' price direction in advance. Along with the technical and fundamental analysis of Bristol Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bristol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1281 | |||
| Jensen Alpha | 0.3415 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.1233 | |||
| Treynor Ratio | (1.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.